French study tracks COVID-19's toll on pregnant women and their babies
NCT ID NCT04463758
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study follows thousands of pregnant women in France who had or likely had COVID-19 during pregnancy or shortly after giving birth. Researchers track health problems in both mothers and newborns up to 12 weeks after delivery, using medical records and questionnaires about mental health. The goal is to better understand how COVID-19 affects pregnancy and newborn outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better understand and manage COVID-19 risks during pregnancy, improving care for mothers and babies.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test any new therapy. Results may not apply to all populations or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AP-HP Cochin
Paris, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Text messages and personal support may reduce pregnancy risks — a trial puts them to the test
- Ultrasound may predict hidden placental problems before delivery
- Can acupuncture and exercise ease pelvic pain during pregnancy?
- Could a simple massage technique ease a common pregnancy pain?
- Sleep program aims to reduce pregnancy risks in african american women
- Could earlier aspirin save lives in sickle cell pregnancies?